Sculier, J P <br/><br/>
Phase III randomized trial comparing moderate-dose cisplatin to combined cisplatin and carboplatin in addition to mitomycin and ifosfamide in patients with stage IV non-small-cell lung cancer.  [electronic resource] 

 -  British journal of cancer  Nov 2000 
 - 1128-35 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0007-0920 
<br/><br/><label>Standard No.: </label>10.1054/bjoc.2000.1413  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alopecia--chemically induced<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Carboplatin--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cisplatin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Leukopenia--chemically induced<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Middle Aged<br/>Mitomycin--administration & dosage<br/>Multivariate Analysis<br/>Neoplasm Staging<br/>Survival Analysis<br/>Survival Rate<br/>Thrombocytopenia--chemically induced<br/>Time Factors<br/>Treatment Outcome